These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 20337033)

  • 1. [Chitosan-siRNA complex nanoparticles for gene silencing].
    Liu X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):97-101. PubMed ID: 20337033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
    Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
    Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An inhalable β₂-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lung.
    Luo Y; Zhai X; Ma C; Sun P; Fu Z; Liu W; Xu J
    J Control Release; 2012 Aug; 162(1):28-36. PubMed ID: 22698944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan as a carrier for targeted delivery of small interfering RNA.
    Rudzinski WE; Aminabhavi TM
    Int J Pharm; 2010 Oct; 399(1-2):1-11. PubMed ID: 20732398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
    Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
    Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional gene silencing mediated by chitosan/siRNA nanocomplexes.
    Ji AM; Su D; Che O; Li WS; Sun L; Zhang ZY; Yang B; Xu F
    Nanotechnology; 2009 Oct; 20(40):405103. PubMed ID: 19752491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.
    Wang J; Feng SS; Wang S; Chen ZY
    Int J Pharm; 2010 Nov; 400(1-2):194-200. PubMed ID: 20801205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
    Zeng P; Xu Y; Zeng C; Ren H; Peng M
    Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. siRNA delivery with chitosan nanoparticles: Molecular properties favoring efficient gene silencing.
    Malmo J; Sørgård H; Vårum KM; Strand SP
    J Control Release; 2012 Mar; 158(2):261-8. PubMed ID: 22119955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choice of the adequate detection time for the accurate evaluation of the efficiency of siRNA-induced gene silencing.
    Choi I; Cho BR; Kim D; Miyagawa S; Kubo T; Kim JY; Park CG; Hwang WS; Lee JS; Ahn C
    J Biotechnol; 2005 Nov; 120(3):251-61. PubMed ID: 16095743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell-specific siRNA delivery using antibody-conjugated chitosan nanoparticles.
    Lee J; Yun KS; Choi CS; Shin SH; Ban HS; Rhim T; Lee SK; Lee KY
    Bioconjug Chem; 2012 Jun; 23(6):1174-80. PubMed ID: 22607555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterisation of chitosan nanoparticles for siRNA delivery.
    Katas H; Alpar HO
    J Control Release; 2006 Oct; 115(2):216-25. PubMed ID: 16959358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonate apatite-facilitated intracellularly delivered siRNA for efficient knockdown of functional genes.
    Hossain S; Stanislaus A; Chua MJ; Tada S; Tagawa Y; Chowdhury EH; Akaike T
    J Control Release; 2010 Oct; 147(1):101-8. PubMed ID: 20620182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAi using a chitosan/siRNA nanoparticle system: in vitro and in vivo applications.
    Andersen MØ; Howard KA; Kjems J
    Methods Mol Biol; 2009; 555():77-86. PubMed ID: 19495689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan Nanoparticles for SiRNA Delivery In Vitro.
    Ragelle H; Vanvarenberg K; Vandermeulen G; Préat V
    Methods Mol Biol; 2016; 1364():143-50. PubMed ID: 26472448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery.
    Lee DW; Yun KS; Ban HS; Choe W; Lee SK; Lee KY
    J Control Release; 2009 Oct; 139(2):146-52. PubMed ID: 19567259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
    Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM
    Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethylendiamine core PAMAM dendrimers/siRNA complexes as in vitro silencing agents.
    Perez AP; Romero EL; Morilla MJ
    Int J Pharm; 2009 Oct; 380(1-2):189-200. PubMed ID: 19577619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of siRNA from lyophilized polymeric surfaces.
    Andersen MØ; Howard KA; Paludan SR; Besenbacher F; Kjems J
    Biomaterials; 2008 Feb; 29(4):506-12. PubMed ID: 17950838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery.
    Park S; Jeong EJ; Lee J; Rhim T; Lee SK; Lee KY
    Carbohydr Polym; 2013 Jan; 92(1):57-62. PubMed ID: 23218265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.